Section 34, The Pharmacy and Drugs Act, 2001

(1) The Board may prohibit the sale of a proprietary drug if in its opinion:— (a) claims are made for the drugs which are unjustified; or (b) details of the composition of the drug furnished under this Act differ substantially from those disclosed on an analysis of samples by a laboratory approved by the Board. (2) Descriptive matter published in relation to a proprietary drug must be in English and should not differ substantially from that contained in copies furnished to the Board in relation to the drug under section 33 and the Board may prohibit the sale of any drug, in respect of which it is satisfied that this subsection has not been complied with. [Margin: Control of publication of descriptive matter.]